Effects of Pravastatin on neuroprotection and neurogenesis after cerebral ischemia in rats

Neuroscience Bulletin

Volumn 23, Issue 4, 2007, Pages 189-197

  Zheng, Zhao ^a   Chen, Bi ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cerebral ischemia; Hydroxymethylglutaryl CoA reductase inhibitors; Neurogenesis

Indexed keywords

BROXURIDINE; CHOLESTEROL; DOUBLECORTIN; MICROTUBULE ASSOCIATED PROTEIN 2; PRAVASTATIN; SODIUM CHLORIDE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CALCULATION; CELL COUNT; CELL MIGRATION; CELL NUCLEUS; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; DENTATE GYRUS; DRUG SAFETY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; RAT; ROTAROD TEST; SUBVENTRICULAR ZONE; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; BRAIN ISCHEMIA; BROMODEOXYURIDINE; CELL COUNT; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; MALE; MICROTUBULE-ASSOCIATED PROTEINS; NEUROLOGIC EXAMINATION; NEURONS; NEUROPEPTIDES; NEUROPROTECTIVE AGENTS; PHOSPHOPYRUVATE HYDRATASE; PRAVASTATIN; RATS; RATS, WISTAR; TIME FACTORS;

EID: 34748896558     PISSN: 16737067     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Reinoso RF, Sanchez Navarro A, Garcia MJ, Prous JR. Preclinical pharmacokinetics of statins. Methods Find Exp Clin Pharmacol 2002, 24: 593-613.
2. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 2003, 326: 1423.
3. Bushneil CD, Newby LK, Goldstein LB, Lin F, Yaffe K, Simon JA. Statin use and stroke outcomes in the heart and estrogen-progestin replacement study (HERS). Neurology 2004, 62: 968-970.
4. Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001, 285: 1711-1718.
5. Greisenegger S, Mullner M, Tentschert S, Lang W, Lalouschek W. Effect of pretreatment with statins on the severity of acute ischemic cerebrovascular events. J Neurol Sci 2004, 221: 5-10.
6. Moonis M, Kane K, Schwiderski U, Sandage BW, Fisher M. HMG-CoA reductase inhibitors improve acute ischemic stroke outcome. Stroke 2005, 36:1298-1300.
7. Kureishi Y, Luo Z, Shiojima I, Bialik A, Fulton D, Lefer DJ, et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 2000, 6: 1004-1010.
8. Chen J, Zhang ZG, Li Y, Wang Y, Wang L, Jiang H, et al. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol 2003, 53: 743-751.
9. Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI3-kinase/Akt pathway. J Clin Invest 2001, 108: 391-397.
10. Llevadot J, Murasawa S, Kureishi Y, Uchida S, Masuda H, Kawamoto A, et al. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest 2001, 108: 399-405.
11. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20: 84-91.
12. Menzies SA, Hoff JT, Betz AL. Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. Neurosurgery 1992, 31: 100-107.
13. Schabitz WR, Berger C, Kollmar R, Seitz M, Tanay E, Kiessling M, et al. Effect of brain-derived neurotrophic factor treatment and forced arm use on functional motor recovery after small cortical ischemia. Stroke 2004, 35: 992-997.
14. Zhang L, Xiao HM, Zhou YX, Luo XP. Priming stimulation modifies synaptic plasticity in the perforant path of hippocampal slice in rat. Neurosci Bull 2006, 22: 227-231.
15. Kluska MM, Witte OW, Bolz J, Redecker C. Neurogenesis in the adult dentate gyrus after cortical infarcts: effects of infarct location, N-methyl-D-aspartate receptor blockade and anti-inflammatory treatment. Neuroscience 2005, 135: 723-735.
16. Jin K, Minami M, Lan JQ, Mao XO, Batteur S, Simon RP, et al. Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat. Proc Natl Acad Sci USA 2001, 98: 4710-4715.
17. Dayer AG, Cleaver KM, Abouantoun T, Cameron HA. New GABAergic interneurons in the adult neocortex and striatum are generated from different precursors. J Cell Biol 2005, 168: 415-427.
18. Brown JP, Couillard-Despres S, Cooper-Kuhn CM, Winkler J, Aigner L, Kuhn HG. Transient expression of doublecortin during adult neurogenesis. J Comp Neurol 2003, 467: 1-10.
19. Francis F, Koulakoff A, Boucher D, Chafey P, Schaar B, Vinet MC, et al. Doublecortin is a developmentally regulated, microtubule-associated protein expressed in migrating and differentiating neurons. Neuron 1999, 23: 247-256.
20. Gould E, Reeves AJ, Graziano MS, Gross CG. Neurogenesis in the neocortex of adult primates. Science 1999, 286: 548-552.
21. Yang HK, Sundholm-Peters NL, Goings GE, Walker AS, Hyland K, Szele FG. Distribution of doublecortin expressing cells near the lateral ventricles in the adult mouse brain. J Neurosci Res 2004, 76: 282-295.
22. Kitagawa K, Matsumoto M, Niinobe M, Mikoshiba K, Hata R, Ueda H, et al. Microtubule-associated protein 2 as a sensitive marker for cerebral ischemic damage - immunohistochemical investigation of dendritic damage. Neuroscience 1989, 31: 401-411.
23. Werner N, Priller J, Laufs U, Endres M, Bohm M, Dirnagl U, et al. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol 2002, 22: 1567-1572.
24. Endres M. Statins: Potential new indications in inflammatory conditions. Atheroscler Suppl 2006, 7: 31-35.
25. Amin-Hanjani S, Stagliano NE, Yamada M, Huang PL, Liao JK, Moskowitz MA. Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Stroke 2001, 32: 980-986.
26. Laufs U, Endres M, Stagliano N, Amin-Hanjani S, Chui DS, Yang SX, et al. Neuroprotection mediated by changes in the endothelial actin cytoskeleton. J Clin Invest 2000, 106: 15-24.
27. Endres M, Laufs U, Huang Z, Nakamura T, Huang P, Moskowitz MA, et al. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci USA 1998, 95: 8880-8885.
28. Gertz K, Laufs U, Lindauer U, Nickenig G, Bohm M, Dirnagl U, et al. Withdrawal of statin treatment abrogates stroke protection in mice. Stroke 2003, 34: 551-557.
29. Laufs U, Gertz K, Dirnagl U, Bohm M, Nickenig G, Endres M. Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice. Brain Res 2002, 942: 23-30.
30. Sironi L, Cimino M, Guerrini U, Calvio AM, Lodetti B, Asdente M, et al. Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage. Arterioscler